Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2007
05/09/2007EP1783124A1 2-phenylthiophene derivative
05/09/2007EP1782832A1 Remedy for diabetes
05/09/2007EP1782829A1 Preventive and/or remedy for hyperkalemia containing ep4 agonist
05/09/2007EP1782828A1 Progression inhibitor for disease attributed to abnormal accumulation of liver fat
05/09/2007EP1782820A1 Method of screening toxin-neutralizing peptide, stx2 inhibitory peptide and vero toxin-neutralizing agent
05/09/2007EP1782818A1 Pharmaceutical composition comprising lactobacilli and symethicone for the treatment of gastrointestinal pathologies
05/09/2007EP1782813A1 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist
05/09/2007EP1781300A1 Muscarinic antagonists with parp and sir modulatng activity as agents for inflammatory diseases
05/09/2007EP1551369A4 Combination therapy for treatment of fibrotic disorders
05/09/2007EP1254907B1 Pyrrolopyridazine compound
05/09/2007EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
05/09/2007EP1180143B1 In vitro methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues, pharmaceutical compositions related thereto
05/09/2007EP1137792B1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
05/09/2007EP0937032B1 Substituted gamma aminobutyric acids as pharmaceutical agents
05/09/2007EP0871734B1 Polypeptide fragments capable of competition with streptococcus mutans antigen i/ii
05/09/2007CN1960977A Quinazoline derivative
05/09/2007CN1960704A Composition, compising hydrofluoric acid, for inhibiting dental erosion
05/09/2007CN1958801A Method for constructing interference plasmid of human fibrinogen hf12 shRNA, and pharmic usage
05/09/2007CN1958772A 药酒 Tincture
05/09/2007CN1958611A Mucin antibody in sera, and usage
05/09/2007CN1958062A Sanitary medicated wine
05/09/2007CN1958056A Medication for treating cold syndrome of disease of acid regurgitation
05/09/2007CN1958050A Composition of Chinese traditional medicine for treating wean rickets, and preparation method
05/09/2007CN1958038A Preparation of Chinese traditional medicine for treating recurrent ulcer of oral cavity
05/09/2007CN1958033A Tiandongqing
05/09/2007CN1958030A Method for preparing capsule for easying astriction
05/09/2007CN1958029A Jingangteng solution type solid dispersion, and application
05/09/2007CN1958022A Animal use compound medicament with effects for hear-clearing and damp-drying drug, strengthening the spleen and aresting dirrhea, and preparation method
05/09/2007CN1958005A Combination of Chinese traditional medicine, preparation method, and quality control method
05/09/2007CN1958004A Capsule of gastric qi through
05/09/2007CN1958000A Method for processing rhizoma coptidis
05/09/2007CN1957998A Animal use compound medicament with effects of removing toxic heat, removing heat from the blood to stop bleeding, and preparation method
05/09/2007CN1957997A Animal use compound medicament with effects of relieving the muscles and skin, clearing away heat, relieving darrhea, and relieving dysentery, and preparation method
05/09/2007CN1957980A Composition of medication in use for preserving health and invigorating qi, and preparation method
05/09/2007CN1957979A Medication with effect of being sobered up from wine and protecting liver, and method for making up preparation
05/09/2007CN1957972A Composition in use for invigorating primordial energy, benefiting pubic region, preparation method and usage
05/09/2007CN1957962A Method for preparing general saponin of golden Chinese gentian and application
05/09/2007CN1957955A Soft capsule of Chinese traditional medicine, preparation method, and quality control method
05/09/2007CN1957950A Product for enhancing physical performance, and preventing tuberculosis, and preparation method
05/09/2007CN1957948A Modified montmorillonite, preparation method and application
05/09/2007CN1957943A Injection of monoamine cysteine of glycyrrhizicacid and preparation
05/09/2007CN1957938A Effervescence tablet of Glucurolactone, and preparation method
05/09/2007CN1957937A Dispersion tablet of Glucurolactone, and preparation method
05/09/2007CN1957936A Silybin tiny pellets and preparation method
05/09/2007CN1957932A Gabexate of methane-sulfonic acid injection, and preparation method
05/09/2007CN1957931A Alkanet for pacifying cheilitis
05/09/2007CN1315185C Electronic device with carrier, method of manufacturing same
05/09/2007CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase
05/09/2007CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase
05/09/2007CN1314444C Medicinal composition for treating diabetes and its complication and viral hepatitis and its preparation method
05/09/2007CN1314440C Spleen fortifying food dispersing oral liquid and its preparation method
05/09/2007CN1314436C Noontime tea volatile oil-beta cyclo dextrin inclusion compound and its preparation technology
05/09/2007CN1314434C Heat-clearing and detoxic medicine and its preparation method
05/09/2007CN1314422C Shiweifuzheng medicine for tonifying qi and blood, warning yang and strengthening spleen and its preparation process
05/09/2007CN1314420C Stomatocace powder
05/09/2007CN1314419C Chinese medicine compound prescription for treating teeth and oral diseases
05/09/2007CN1314410C Chinese medicinal formulation for health-care and heptitis treatment
05/09/2007CN1314407C Compound vitamin U atropa belladonna bismuth-aluminium medicine table for treating gastric ulcer
05/09/2007CN1314406C Application of montmorillonite in pharmacy
05/09/2007CN1314404C Health care craem for oral taking and external use and its preparation
05/09/2007CN1314403C Composition of paeoniflorin and albiflorin and its preparation method
05/09/2007CN1314401C Polyenic phosphatide acylcholine freeze-dried powder injecta medicine
05/09/2007CN1314390C Pharmaceutical dosage form with multiple coatings
05/08/2007US7214716 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives
05/08/2007US7214712 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
05/08/2007US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists
05/08/2007US7214692 Medical use for tachykinin antagonists
05/08/2007US7214689 Isoquinoline compounds
05/08/2007US7214688 Compounds
05/08/2007US7214687 Quinuclidine derivatives and medicinal compositions containing the same
05/08/2007US7214680 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
05/08/2007US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease;
05/08/2007US7214678 Having antiinflammatory, anti-pyretic and anti-diarrheal properties
05/08/2007US7214677 Benzamide, heteroarylamide and reverse amides
05/08/2007US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
05/08/2007US7214674 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
05/08/2007US7214668 Viricides; anticancer agents; liver disorders
05/08/2007US7214512 Genomic mammary Amyloid a sequence
05/08/2007US7214393 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent
05/08/2007US7214370 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
05/08/2007CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
05/08/2007CA2276098C Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines
05/08/2007CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists
05/08/2007CA2230406C Antimicrobial caries-detecting composition
05/03/2007WO2007049914A1 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
05/03/2007WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient
05/03/2007WO2007049818A1 Anti-fatty liver, anti-obesity or hypolipidemic composition
05/03/2007WO2007049798A1 Novel benzoxathiin derivative
05/03/2007WO2007049757A1 Inhibitor of osteoclast formation, composition for oral administration and prophylactic or therapeutic agent for bone disease comprising lactoferrin-containing liposome
05/03/2007WO2007049586A1 Therapeutic agent for ulcerative colitis and/or crohn's disease
05/03/2007WO2007049424A1 Hepatic fibrosis inhibitor
05/03/2007WO2007049361A1 Liver fibrosis inhibitor
05/03/2007WO2007048847A2 Indole and azaindole derivatives for the treatment of inflammatory and autoimmune diseases
05/03/2007WO2007048643A1 Novel compound
05/03/2007WO2006109344A3 Composition to be used for the treatment of parodontal pathologies
05/03/2007US20070099991 Selective rxr ligands
05/03/2007US20070099981 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
05/03/2007US20070099980 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
05/03/2007US20070099975 Imidazole derivatives modulating the sodium channels
05/03/2007US20070099953 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis